| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003092619A3 Prevention and treatment of type 2 diabetes |
| 10/07/2004 | WO2003072603A9 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002068451A3 Sperm protein 17 for the diagnosis and treatment of cancer |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198954 Gram negagtive bacterial polypeptide for use in diagnosis, prevention and treatment of swine respiratory system infection disorders; veterinary medicine; vaccine development |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198951 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198684 Vaccine comprising polynucleotides |
| 10/07/2004 | US20040198680 Dna bacteria; activate lymphocytes; nucleotide sequences; antigens; administering cytokines |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198635 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 10/07/2004 | US20040197914 Viral delivery systems and related manufacture and use |
| 10/07/2004 | US20040197912 Expression vector comprising nucleotide sequences coding tumor antigens for use in development cancer vaccines; immunotherapeutics |
| 10/07/2004 | US20040197910 Gene regulation in transgenic animals using a transposon-based vector |
| 10/07/2004 | US20040197901 Ancillary composition for the preparation of committed mature dentritic cells |
| 10/07/2004 | US20040197896 Identifying genes associated with mycobacterial viability and virulence for use in designing modulators for treatment and prevention of infection |
| 10/07/2004 | US20040197872 can be used in single or dual purpose and porcine reproductive respiratory syndrome virus vector vaccines; genetic engineering |
| 10/07/2004 | US20040197869 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197823 Compositions and methods for aa4rp assay |
| 10/07/2004 | US20040197798 Using alteration in phosphorylation to detect, diagnose, prevent and prognose cell proliferative disorders |
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197782 Nucleic acid sequences mixture for detection of cutaneous t-cell lymphomas (CTCL); antitumor agents |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197351 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine |
| 10/07/2004 | US20040197350 Immunizing compositions and methods of use |
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197348 Enhanced immune response to attachment (G) protein of respiratory Syncytial virus |
| 10/07/2004 | US20040197347 Induce immunology response; isoation antigen; administering polynucleotide in carrier |
| 10/07/2004 | US20040197344 Human Leukocyte Antigen (HLA)-based HIV vaccine |
| 10/07/2004 | US20040197343 Attenuated for cell proliferation; repair nucleic acids; vaccines against cancer, infections |
| 10/07/2004 | US20040197341 Therapeutic process for p. aeruginosa infections using macrolide antibiotics |
| 10/07/2004 | US20040197337 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 10/07/2004 | US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins |
| 10/07/2004 | US20040197332 antiproliferative agents; antitumor and anticancer agents; monoclonal antibodies produced by hybridomas cell ling |
| 10/07/2004 | US20040197331 Induction of cytotoxic T-lymphocyte responses |
| 10/07/2004 | US20040197328 Screening; separation using cancer cytotoxicity; diagnosis; anticancer, antitumor agents; administering monoclonal antibodies |
| 10/07/2004 | US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents |
| 10/07/2004 | US20040197325 Antibodies against GPR64 and uses thereof |
| 10/07/2004 | US20040197324 High concentration antibody and protein formulations |
| 10/07/2004 | US20040197314 gene expression of polypeptide in membrane vesicle ; forming antibodies; controlling immunology response |
| 10/07/2004 | US20040197312 Anticancer agents; synergistic mixture of vaccine and antibodies , interferon or drug |
| 10/07/2004 | US20040197306 Polypeptides; used in diagnosis of gastrointestinal disorders; psoriasis;inflammatory bowel disorders; respiratory system disorders; antiallergens; atherosclerosis |
| 10/07/2004 | US20040197305 Immuno-modulating effects of chemokines in dna vaccination |
| 10/07/2004 | CA2731275A1 Tumour-associated peptides binding to mhc-molecules |
| 10/07/2004 | CA2519922A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | CA2519528A1 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 10/07/2004 | CA2519313A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 10/07/2004 | CA2519227A1 Nogo receptor binding protein |
| 10/07/2004 | CA2519165A1 Hiv-peptide-carrier-conjugates |
| 10/07/2004 | CA2519114A1 Methods and compositions for treating and preventing inflammatory conditions |
| 10/07/2004 | CA2519025A1 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 10/07/2004 | CA2518854A1 Treating immunological disorder using agonists of interleukin-21/interleukin-21 receptor |
| 10/07/2004 | CA2518793A1 Methods of inducing immunotolerance and compositions for use therein |
| 10/07/2004 | CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | CA2517839A1 Melan-a peptide analogue-virus-like-particle conjugates |
| 10/07/2004 | CA2517675A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 10/07/2004 | CA2517673A1 Improved vaccines for preventing viral infection |
| 10/07/2004 | CA2515298A1 Modified free-living microbes, vaccine compositions and methods of use thereof |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464702A1 Method of stabilizing protein |
| 10/06/2004 | EP1463949A2 Diagnostics and vaccines for mycobacterium paratuberculosis infections |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463827A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/06/2004 | EP1463819A1 Hiv-1 virus tat-protein mutants |
| 10/06/2004 | EP1463761A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 10/06/2004 | EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 10/06/2004 | EP1463757A2 Antisense compounds directed against human csf-1 |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463753A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 10/06/2004 | EP1463751A2 Albumin fusion proteins |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463733A2 Mitotic kinesin inhibitors |
| 10/06/2004 | EP1463558A2 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 10/06/2004 | EP1463527A2 The use of gammaglobulin for the treatment of immune-mediated diseases |
| 10/06/2004 | EP1463526A2 Early detection of mycobacterial disease using peptides |
| 10/06/2004 | EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/06/2004 | EP1463524A2 METHODS OF THERAPY FOR NON−HODGKIN S LYMPHOMA |
| 10/06/2004 | EP1463522A1 Human antipneumococcal antibodies from non-human animals |
| 10/06/2004 | EP1463521A2 Gp41 inhibitor |
| 10/06/2004 | EP1463520A2 Immunisation against chlamydia trachomatis |
| 10/06/2004 | EP1463519A2 Vaccine |
| 10/06/2004 | EP1463479A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 10/06/2004 | EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 10/06/2004 | EP1349868B1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 10/06/2004 | EP1272652B1 Herpes viruses for immune modulation |
| 10/06/2004 | EP1096954B1 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 10/06/2004 | EP1073464B1 Monoclonal antibodies with reduced immunogenicity |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1062514B1 C-myc coding region determinant-binding protein (crd-bp) |
| 10/06/2004 | EP0977588B1 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |